Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2252934
Max Phase: Preclinical
Molecular Formula: C80H129N17O13S
Molecular Weight: 1569.08
Molecule Type: Protein
Associated Items:
ID: ALA2252934
Max Phase: Preclinical
Molecular Formula: C80H129N17O13S
Molecular Weight: 1569.08
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
Standard InChI: InChI=1S/C80H129N17O13S/c1-12-53(11)69(80(108)94-65(44-50(6)7)75(103)89-61(32-20-24-40-83)73(101)95-68(51(8)9)79(107)91-63(70(85)98)42-48(2)3)96-74(102)62(33-21-25-41-84)87-71(99)59(30-18-22-38-81)88-77(105)66(45-54-26-14-13-15-27-54)93-76(104)64(43-49(4)5)92-72(100)60(31-19-23-39-82)90-78(106)67(46-55-47-86-58-29-17-16-28-57(55)58)97-111(109,110)56-36-34-52(10)35-37-56/h13-17,26-29,34-37,47-51,53,59-69,86,97H,12,18-25,30-33,38-46,81-84H2,1-11H3,(H2,85,98)(H,87,99)(H,88,105)(H,89,103)(H,90,106)(H,91,107)(H,92,100)(H,93,104)(H,94,108)(H,95,101)(H,96,102)/t53-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-/m0/s1
Standard InChI Key: VUAAQDAZXMDMSS-KDBSVTHLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1569.08 | Molecular Weight (Monoisotopic): 1567.9676 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ferre R, Badosa E, Feliu L, Planas M, Montesinos E, Bardají E.. (2006) Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides., 72 (5): [PMID:16672470] [10.1128/aem.72.5.3302-3308.2006] |
Source(1):